Post-ECT Agitation and Combativeness: Causes and Management
Agitation upon awakening from ECT is a recognized adverse effect that occurs in approximately 12-18% of patients, with multiple contributing factors including postictal confusion, anesthetic effects, prolonged seizures, inadequate muscle relaxation, and treatment-emergent mania. 1, 2
Primary Causes
Postictal Confusion and Delirium
The most common cause is postictal confusion, which typically manifests as restlessness and disorientation immediately following the seizure. This confusional state usually resolves within one hour and occurs most frequently during the initial treatments of a series 3. The confusion and disorientation seen upon awakening after ECT typically clear within an hour 1.
Anesthetic-Related Factors
Inadequate muscle relaxation with succinylcholine is a significant contributor to emergence agitation. Evidence demonstrates that patients who showed troublesome restless emergence agitation with succinylcholine doses around 0.7 mg/kg showed no agitation when the dose was increased to 1.0 mg/kg 4. This suggests that patients predisposed to emergence agitation are sensitive to seizure-induced metabolic changes in skeletal muscle tissue, and the likelihood of emergence agitation rises with the ratio of skeletal muscle mass to succinylcholine dose 4.
Prolonged or Inadequate Seizures
Prolonged seizures (lasting >180 seconds) are clinically significant because they are associated with greater postictal confusion and amnesia 1. Resources necessary for the management of agitation must be available in the recovery area 1.
Treatment-Emergent Mania
Manic or hypomanic symptoms may manifest themselves during the recovery period and can be induced during a course of ECT 1. If this occurs, changing from unilateral to bilateral ECT may be indicated 1.
Neurobiological Changes
Recent evidence shows that postictal agitation is associated with brain-wide immediate postictal diffusivity changes, including decreased fractional anisotropy and increased mean diffusivity in white matter 5. These microstructural changes suggest a clinically relevant role of tissue alterations shortly after an ECT-induced seizure.
Clinical Predictors and Patterns
Important clinical patterns to recognize:
- Patients who become excited early in the treatment course rarely manifest this phenomenon at all subsequent treatments 6
- Only 34.3% of treatments resulted in postictal excitement in patients who had previously experienced it 6
- The occurrence of delirium in one treatment is not a harbinger of its reappearance in later treatments 3
Management Approach
Immediate Management
Gentle reassurance is sufficient for most patients, but pharmacological intervention may be warranted in severe cases 3. Options include:
- Diazepam
- Midazolam
- Additional methohexital
- Lorazepam
- Droperidol (in some instances)
Monitoring Requirements
Close monitoring should be provided during and after treatment until the patient is fully recovered from anesthesia 1. Monitoring should include:
- Observation of seizure duration
- Airway patency
- Agitation levels
- Vital signs
- Adverse effects
After treatment, observation should be provided in a designated recovery area with provision for expert nursing care for 1-2 hours or as clinically necessary 1.
Prevention Strategies
- Optimize succinylcholine dosing - Consider increasing to approximately 1.0 mg/kg in patients with recurrent emergence agitation 4
- Monitor for treatment-emergent mania - Be prepared to switch from unilateral to bilateral electrode placement if manic symptoms develop 1
- Manage prolonged seizures promptly - Terminate seizures >180 seconds with additional methohexital, diazepam, or lorazepam 1
Important Caveats
- It is not necessary to routinely use postseizure benzodiazepines in all patients who have once exhibited postictal excitement, as the pattern is often inconsistent 6
- Adolescents may have lower seizure thresholds and more prolonged seizures with ECT than adults, potentially increasing risk 1
- The phenomenon is generally self-limited and does not predict poor treatment outcome 6